Free Trial

This company has been marked as potentially delisted and may not be actively trading.

Clearside Biomedical (CLSD) Stock Forecast & Price Target

Clearside Biomedical logo
Get the Latest News and Ratings for CLSD and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Clearside Biomedical and its competitors.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CLSD Analyst Ratings Over Time

TypeCurrent Forecast
5/7/25 to 5/7/26
1 Month Ago
4/7/25 to 4/7/26
3 Months Ago
2/6/25 to 2/6/26
1 Year Ago
5/7/24 to 5/7/25
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
1 Buy rating(s)
1 Buy rating(s)
1 Buy rating(s)
4 Buy rating(s)
Hold
5 Hold rating(s)
5 Hold rating(s)
5 Hold rating(s)
0 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$56.25$56.25$63.00$78.75
Forecasted Upside13,619.51% Upside13,619.51% Upside17,547.06% Upside516.92% Upside
Consensus RatingHoldHoldHoldBuy

CLSD Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

CLSD Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Clearside Biomedical Stock vs. The Competition

TypeClearside BiomedicalMedical CompaniesS&P 500
Consensus Rating Score
2.00
2.30
2.52
Consensus RatingHoldHoldModerate Buy
Predicted Upside13,619.51% Upside913.07% Upside14.04% Upside
News Sentiment Rating
Neutral News

See Recent CLSD News
Positive News
Positive News
DateBrokerageAnalystActionRatingPrice TargetReport Date
Upside/Downside
Details
11/18/2025
Serge Belanger
Serge Belanger
4 of 5 stars
Reiterated RatingHold
11/1/2025 Initiated CoverageSell (E+)
7/18/2025
HC Wainwright logo
HC Wainwright
3 of 5 stars
Yi Chen
2 of 5 stars
DowngradeBuyNeutral$75.00+730.84%
7/18/2025DowngradeBuyNeutral
7/18/2025 DowngradeBuyHold$30.00+232.34%
7/17/2025 DowngradeStrong-BuyHold
5/16/2025Reiterated RatingMarket Outperform$75.00 ➝ $75.00+466.89%
6/25/2024 Initiated CoverageOutperform$75.00+362.96%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 01:04 PM ET.


CLSD Forecast - Frequently Asked Questions

According to the research reports of 7 Wall Street equities research analysts, the average twelve-month stock price forecast for Clearside Biomedical is $56.25, with a high forecast of $75.00 and a low forecast of $30.00.

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Clearside Biomedical in the last year. There is currently 1 sell rating, 5 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" CLSD shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CLSD, but not buy additional shares or sell existing shares.

According to analysts, Clearside Biomedical's stock has a predicted upside of 13,619.51% based on their 12-month stock forecasts.

Analysts like Clearside Biomedical less than other "medical" companies. The consensus rating score for Clearside Biomedical is 2.00 while the average consensus rating score for "medical" companies is 2.30. Learn more on how CLSD compares to other companies.


This page (NASDAQ:CLSD) was last updated on 5/7/2026 by MarketBeat.com Staff.
From Our Partners